(19)
(11) EP 1 332 146 A2

(12)

(88) Date of publication A3:
15.08.2002

(43) Date of publication:
06.08.2003 Bulletin 2003/32

(21) Application number: 01978721.7

(22) Date of filing: 23.10.2001
(51) International Patent Classification (IPC)7C07D 487/10, A61K 31/527, A61P 29/00, A61P 35/00, C07D 471/10
// (C07D487/10, 239:00), C07D209:00,(C07D471/10, 239:00), C07D221:00
(86) International application number:
PCT/IB0101/986
(87) International publication number:
WO 0203/4753 (02.05.2002 Gazette 2002/18)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 26.10.2000 US 243389 P

(71) Applicant: Pfizer Products Inc.
Groton,Connecticut 06340 (US)

(72) Inventors:
  • BRONK, Brian, Scott,Pfizer Global Res. a. Devel.
    Groton, CT 06340 (US)
  • NOE, Mark, Carl,Pfizer Global Res. a. Devel.
    Groton, CT 06340 (US)
  • WYTHES, Martin, James,Pfizer Global Res. a. Devel
    Groton, CT 06340 (US)

(74) Representative: Hirsch, Denise Marie et al
Pfizer Global Research and DevelopmentFresnes Laboratories3-9, rue de la LogeB.P. 100
94265 Fresnes Cedex
94265 Fresnes Cedex (FR)

   


(54) SPIRO-PYRIMIDINE-2,4,6-TRIONE METALLOPROTEINASE INHIBITORS